148 related articles for article (PubMed ID: 2514192)
1. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles.
Owen EJ; Davies MC; Kingsland CR; Jacobs HS; Mason BA
Hum Reprod; 1989 Oct; 4(7):749-53. PubMed ID: 2514192
[TBL] [Abstract][Full Text] [Related]
2. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.
Rutherford AJ; Subak-Sharpe RJ; Dawson KJ; Margara RA; Franks S; Winston RM
Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1765-8. PubMed ID: 3136830
[TBL] [Abstract][Full Text] [Related]
3. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.
Van der Elst J; Van den Abbeel E; Camus M; Smitz J; Devroey P; Van Steirteghem A
Hum Reprod; 1996 Oct; 11(10):2097-106. PubMed ID: 8943509
[TBL] [Abstract][Full Text] [Related]
4. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program.
Abdalla HI; Ahuja KK; Leonard T; Morris NN; Honour JW; Jacobs HS
Fertil Steril; 1990 Mar; 53(3):473-8. PubMed ID: 2106453
[TBL] [Abstract][Full Text] [Related]
5. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
[TBL] [Abstract][Full Text] [Related]
6. [The beneficial effects of short-term administration of a LHRH agonist (buserelin) in in vitro fertilization].
Loumaye E; de Cooman S; Psalti I; Schrurs B; Adam T; Depreester S; Thomas K
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):1081-7. PubMed ID: 3148649
[TBL] [Abstract][Full Text] [Related]
7. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
Tanbo T; Dale PO; Abyholm T
Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
[TBL] [Abstract][Full Text] [Related]
8. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT.
Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990
[TBL] [Abstract][Full Text] [Related]
9. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
[TBL] [Abstract][Full Text] [Related]
10. Long gonadotrophin releasing hormone agonist/human menopausal gonadotrophin protocol for ovarian stimulation in intrauterine insemination treatment.
Nuojua-Huttunen S; Tuomivaara L; Juntunen K; Tomás C; Martikainen H
Eur J Obstet Gynecol Reprod Biol; 1997 Jul; 74(1):83-7. PubMed ID: 9243209
[TBL] [Abstract][Full Text] [Related]
11. The results of an in vitro fertilization program: two regimens of superovulation.
Grochowski D; Wołczyński S; Kuczyński W; Kulikowski M; Szamatowicz M
Gynecol Endocrinol; 1995 Mar; 9(1):59-62. PubMed ID: 7793301
[TBL] [Abstract][Full Text] [Related]
12. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.
Macnamee MC; Howles CM; Edwards RG; Taylor PJ; Elder KT
Fertil Steril; 1989 Aug; 52(2):264-9. PubMed ID: 2502441
[TBL] [Abstract][Full Text] [Related]
13. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.
Tan SL; Maconochie N; Doyle P; Campbell S; Balen A; Bekir J; Brinsden P; Edwards RG; Jacobs HS
Am J Obstet Gynecol; 1994 Aug; 171(2):513-20. PubMed ID: 8059833
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles.
Lockwood GM; Pinkerton SM; Barlow DH
Hum Reprod; 1995 Feb; 10(2):293-8. PubMed ID: 7769051
[TBL] [Abstract][Full Text] [Related]
15. Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment.
Lejeune B; Barlow P; Puissant F; Delvigne A; Vanrysselberge M; Leroy F
Fertil Steril; 1990 Sep; 54(3):475-81. PubMed ID: 2118860
[TBL] [Abstract][Full Text] [Related]
16. Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial.
Avrech OM; Goldman GA; Pinkas H; Amit S; Neri A; Zukerman Z; Ovadia J; Fisch B
Gynecol Endocrinol; 1996 Jun; 10(3):165-70. PubMed ID: 8862491
[TBL] [Abstract][Full Text] [Related]
17. Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose.
Buckett WM; Bentick B; Shaw RW
Hum Reprod; 1998 Apr; 13(4):811-4. PubMed ID: 9619529
[TBL] [Abstract][Full Text] [Related]
18. The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women.
Smitz J; Van Den Abbeel E; Bollen N; Camus M; Devroey P; Tournaye H; Van Steirteghem AC
Hum Reprod; 1992 Sep; 7(8):1098-102. PubMed ID: 1400933
[TBL] [Abstract][Full Text] [Related]
19. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.
Balen AH; Tan SL; MacDougall J; Jacobs HS
Hum Reprod; 1993 Jun; 8(6):959-64. PubMed ID: 8345091
[TBL] [Abstract][Full Text] [Related]
20. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
